IL-12 was also negatively correlated with depression in non-acral melanoma with TNM stages 0 and I, and with low QOL in non-acral melanoma TNM stages 0 and I. In addition, the IL-12b gene mutation was significantly associated with a low HADS-A score. Here, IL12B is linked to depressive symptom measurement.